IBM Just Got Hit With a 13% Stock Drop—Because AI Can Now Rewrite Ancient Code
🔥 WHAT HAPPENED Remember when your bank's ATM went down for "system maintenance" and you couldn't get cash? Or when an airline's booking
🔥 WHAT HAPPENED Remember when your bank's ATM went down for "system maintenance" and you couldn't get cash? Or when an airline's booking
Microsoft's AI division has been quietly working on Copilot Pro, and a recent leak suggests it might be the first AI that can
🇮🇳 India Just Rewrote the AI Rulebook—And Silicon Valley Is Scrambling to Catch Up 🔥 WHAT HAPPENED Remember when AI summits
The Great Tech Exodus: Wall Street Realizes AI ROI Is A Problem 🔥 WHAT HAPPENED Remember when everyone said "the
The Story: Amazon's Kiro AI system triggered a catastrophic outage affecting millions of users worldwide. The kicker? AWS
TSMC's Q2 2026 net profit soared 77.4% to a record NT$706.56 billion on $40.2 billion in revenue — the clearest proof yet that the AI boom is real, paid-for, and printing cash.
🔥 Gigabyte Just Dropped a $400 WOLED Gaming Monitor and It Changes Everything...
The AI chip company Cerebras Systems — the most prominent challenger to Nvidia's GPU empire — hit the Nasdaq on Thursday under the ticker CBRS and...
> In 2025, startups discovered AI. In 2026, the winners figured out which tools to use and when. Here's the stack the smartest founders are runni...
Developer documentation is the silent killer of product adoption. A 2025 study by the Developer Marketing Alliance found that 67% of developers will a...
Vera Therapeutics just won FDA accelerated approval for TRUTAKNA, the first dual BAFF/APRIL inhibitor for IgA nephropathy — priced at $425,000 a year. Here's why the two-target bet matters.
Feature Image: https://images.unsplash.com/photo-1648792940059-3b782a7b8b20?crop=entropy&cs=tinysrgb&fit=max&fm=jpg&ixid=M3w3ODQzODd8MHwxfHNlYXJj...
BREAKING NEWS — In a move that signals the pharmaceutical industry's full-scale embrace of artificial intelligence, Swiss healthcare giant Roche has ...